CX3CR1 and atherosclerosis: Furthermore, literature searches revealed various other studies that focused on the amelioration of atherosclerosis and related disorders by disrupting chemokine signaling, which focused for example on CX3CR1, MIF, CXCR3, and the CCL5-CXCL4 heterodimer (Table 1).